Profile of Nagoya University Hospital 2012

• Idea/Basic Decision
• Declaration Regarding Patients' Rights and Responsibilities
• Message From the Director

• Idea, Basic Decision, History
• Organization Chart of University Hospital
• Organization Chart of Administration Office
• Chronological List of Directors of University Hospital
• Established Date of Clinical Departments
• Clinical Departments
• Legal Authorization of Medical Services
• University Hospital Staff, Number of Staffs
• Number of Beds
• Patient Services in the University Hospital in 2011
• Clinical Indicator
• Access

Rheumatology

Director ISHIGURO, Naoki (Professor)   8W

Diversified actions include providing information on the treatment of rheumatism

We treat patients with rheumatic diseases that cause damage to motor organs such as joints.

Medical Care System

We perform surgical therapy and drug therapy for patients with rheumatic diseases. In addition, our department is one of the few facilities that are committed to the treatment of hemophilic arthropathy, and we safely perform surgeries in cooperation with Hematology Department. We cooperate closely with departments such as Respirology, Nephrology, and Gastroenterology and are ready to manage complications and adverse drug reactions.

Target Disease

Rheumatoid arthritis (about 1,000 registered patients) and hemophilic arthropathy (three to five surgeries per year).

Strong Fields

We aim at minimally invasive and precise surgery and actively perform surgical therapy. For drug therapy, we basically use methotrexate and actively use biologic drugs as well. In addition, we make comparisons with inflammatory markers, bone metabolic markers, and so forth, and utilize the findings for a better understanding of the pathology and to establish treatment strategies.

Clinical Results

We perform implantation of joint prosthesis in 60 patients a year and use biologic drugs in about 300 patients a year. To provide information on advancements in treating rheumatism, we launched a rheumatism network and hold study meetings and open lectures.

Specialized Outpatient Clinic

Rheumatism outpatient clinic and hemophilia outpatient clinic.

Advanced Medicine and Research

We actively conduct clinical studies for drug development; we are conducting clinical studies for the development of five antirheumatic drugs. We focus our attention on cartilage matrix degradation products and promote the development of joint destruction markers.